Australia's Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnea, a condition ...

SEATTLE -- Weight loss drugs have gained momentum as treatment for obstructive sleep apnea (OSA) at sleep clinics across the ...

Spirair, Inc., an early-stage company developing minimally invasive solutions to help ENTs improve patient care, today announced the publication of the first clinical study evaluating its SeptAligntm ...